HealthVaccine or Treatment Milestone2026-05-15🇺🇸
FDA blocks melanoma drug amid confusion involving Dr. Makary
source: Food and Drug Administration -> target: Drug developer of RP1 / melanoma patients
On 2026-05-15, the U.S. Food and Drug Administration withheld approval of the melanoma drug RP1, according to the article. The decision affected patients and oncologists involved in the trial and was reported as a setback for drug development.
0.26Significance4.0Magnitude0.5Systemic0.6Market1Articles
Location
Silver SpringMarylandNorth AmericaUnited StatesNorth America38.994, -77.009
Story Links